Oragenics, Inc. (OGEN)
0.9351
-0.03
(-3.39%)
USD |
NYAM |
Dec 11, 16:00
0.9351
0.00 (0.00%)
After-Hours: 18:49
Oragenics Research and Development Expense (Quarterly): 0.9309M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.492B |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 2.526M |
| Theriva Biologics, Inc. | 2.551M |
| NanoViricides, Inc. | 0.9931M |